Latest Distribution Agreements News

NTAW Holdings has terminated its Australian Dunlop tyre distribution agreements, entering new contracts with Sumitomo Rubber Industries and Goodyear entities, while continuing Dunlop distribution in New Zealand. The move marks a strategic pivot as NTAW aims to grow other business units and reduce costs.

Neuren Pharmaceuticals reports a robust 11% rise in DAYBUE™ US net sales for Q1 2025, alongside a 17% jump in royalty income, setting the stage for an anticipated European market entry in early 2026.

Zimi Limited has paused its planned capital raising amid ongoing talks, while revealing strong operational momentum including $1.42 million in open orders and expanded market partnerships.

Zeotech Limited has signed a non-binding MOU with global trading giant MSI to negotiate offtake agreements for its Toondoon Kaolin Project, potentially unlocking significant early cash flow and enhanced mining economics.

Nuchev Limited has entered an exclusive sales agency agreement with Brauer Natural Medicines and H&S Brand Corporation, expanding its footprint in Australia's natural and complementary medicines sector. The deal covers key brands including Brauer, Skin Physics, and Rapid Loss, with potential for broader ANZ distribution.

Wide Open Agriculture Limited has clarified that its recently signed offtake and distribution agreement with Univar Solutions China carries no immediate financial impact, outlining a phased market entry and sales timeline.

Zimi Limited confirms $1.42 million in open orders with key distributor GSM Electrical, backed by shareholder approval for up to $6 million in future sales. The company also advances its commercial market ambitions through a new partnership with Zencontrol.

Heavy Minerals Limited is on the cusp of releasing its Port Gregory Garnet Project Pre-Feasibility Study, while simultaneously exploring a promising new industrial minerals opportunity and advancing funding efforts.

RooLife Group reported a strategic quarter marked by the launch of its TikTok UK marketplace, expansion of its own health product range, and a significant capital raise backed by a key Chinese partner.

Inventis Limited reported solid Q3 cash generation and strong technology sales growth, while actively pursuing international expansion and a $2.5 million USD capital raise for its US Hazavoid entity.

Cann Group Limited reported a 20% rise in Q3 production and improved operating cash flow, while navigating a 38% sales dip due to order timing. The company bolstered its balance sheet with new funding and expanded its Botanitech distribution network.

Tissue Repair Limited reports progress in its Phase 3 clinical trials for TR987® despite enrollment delays caused by US regulatory disruptions, while TR Pro+® sales hit record highs and manufacturing scale-up advances.